Compare COYA & ZVIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COYA | ZVIA |
|---|---|---|
| Founded | 2020 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 124.8M | 126.3M |
| IPO Year | 2022 | 2021 |
| Metric | COYA | ZVIA |
|---|---|---|
| Price | $4.71 | $1.35 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 4 |
| Target Price | ★ $15.80 | $4.93 |
| AVG Volume (30 Days) | 166.6K | ★ 385.3K |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 55.88 |
| EPS | N/A | ★ N/A |
| Revenue | $7,945,753.00 | ★ $161,259,000.00 |
| Revenue This Year | N/A | $8.30 |
| Revenue Next Year | $763.10 | $6.87 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 123.57 | 4.01 |
| 52 Week Low | $3.71 | $1.11 |
| 52 Week High | $7.75 | $3.22 |
| Indicator | COYA | ZVIA |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 43.16 |
| Support Level | N/A | $1.13 |
| Resistance Level | N/A | $1.53 |
| Average True Range (ATR) | 0.00 | 0.10 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 0.00 | 29.19 |
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.
Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified. It offers a platform of products that include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers, Kidz drinks, and Sparkling Water. Its products are distributed across the U.S. and Canada through a network of retailers in the food, drug, mass, natural, and e-commerce channels. The company derives a majority of its revenue from the United States.